BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevallay M, Bollschweiler E, Chandramohan SM, Schmidt T, Koch O, Demanzoni G, Mönig S, Allum W. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci 2018;1434:132-8. [PMID: 30138540 DOI: 10.1111/nyas.13954] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Jiang Q, Yue C, Wang Q. Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study. Int J Gen Med 2021;14:10303-14. [PMID: 34992445 DOI: 10.2147/IJGM.S341405] [Reference Citation Analysis]
2 Gao P, Cai N, Yang X, Yuan Z, Zhang T, Lu M, Jin L, Ye W, Suo C, Chen X. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China. Int J Cancer 2021. [PMID: 34498732 DOI: 10.1002/ijc.33801] [Reference Citation Analysis]
3 Hu X, Wu L, Liu B, Chen K. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Front Immunol 2021;12:651056. [PMID: 34122409 DOI: 10.3389/fimmu.2021.651056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xiong J, Kang W, Ma F, Liu H, Ma S, Li Y, Jin P, Hu H, Tian Y. Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction. Front Surg 2021;8:622821. [PMID: 34820414 DOI: 10.3389/fsurg.2021.622821] [Reference Citation Analysis]
5 Wang Y, Sun H, Zhu N, Wu X, Sui Z, Gong L, Yu Z. Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma. Front Oncol 2021;11:640080. [PMID: 33854974 DOI: 10.3389/fonc.2021.640080] [Reference Citation Analysis]
6 Cheng J, Cai M, Shuai X, Gao J, Wang G, Tao K. Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis. Ther Adv Med Oncol 2019;11:1758835919838963. [PMID: 31044021 DOI: 10.1177/1758835919838963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Zhang YJ, Wang YY, Yang Q, Li JB. Scaphoid metastasis as the first sign of occult gastroesophageal junction cancer: A case report. World J Clin Cases 2020; 8(7): 1287-1294 [PMID: 32337204 DOI: 10.12998/wjcc.v8.i7.1287] [Reference Citation Analysis]
8 Zhang X, Wang H, Han Y, Zhu M, Song Z, Zhan D, Jia J. NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway. Onco Targets Ther 2020;13:11315-26. [PMID: 33177839 DOI: 10.2147/OTT.S276868] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Song D, Tian J, Hu Y, Wei Y, Lu H, Wang Y, Guan Q, Zhou Y. Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database. Medicine (Baltimore) 2020;99:e23605. [PMID: 33371094 DOI: 10.1097/MD.0000000000023605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Schlottmann F, Casas MA, Molena D. Evidence-based approach to the treatment of esophagogastric junction tumors. World J Clin Oncol 2022; 13(3): 159-167 [DOI: 10.5306/wjco.v13.i3.159] [Reference Citation Analysis]
11 Chen J, Xia YJ, Liu TY, Lai YH, Yu JS, Zhang TH, Ooi S, He YL. Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data. BMC Cancer 2021;21:532. [PMID: 33971833 DOI: 10.1186/s12885-021-08249-x] [Reference Citation Analysis]
12 Gossage JA. Minimally invasive left-sided esophagectomy (MILO): a novel approach for locally advanced tumors of the gastroesophageal junction. Dis Esophagus 2021;34:doaa059. [PMID: 32591785 DOI: 10.1093/dote/doaa059] [Reference Citation Analysis]
13 Zhang X, Zhu M, Wang H, Song Z, Zhan D, Cao W, Han Y, Jia J. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway. Gene 2021;766:145163. [PMID: 32980450 DOI: 10.1016/j.gene.2020.145163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xiong J, Wang Y, Kang W, Ma F, Liu H, Ma S, Li Y, Jin P, Hu H, Tian Y. Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction. Front Oncol 2020;10:595793. [PMID: 33392090 DOI: 10.3389/fonc.2020.595793] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Wang R, Wu X, Song Y, Lin R, Zheng Z, Jiang K, Liu W, Tang M. 20-Year Trends in Detection Rates of Cardia Cancer via Endoscopic Surveillance in Tianjin, China: A Hospital-Based Study. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1505655] [Reference Citation Analysis]
16 Chu LY, Zhou JY, Zhao YX, Ou YT, Yang T, Peng YH, Fang WK, Xu YW, Xie JJ. Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor. Biosci Rep 2021;41:BSR20204117. [PMID: 34085702 DOI: 10.1042/BSR20204117] [Reference Citation Analysis]
17 Koch OO, Weitzendorfer M, Varga M, Tschoner A, Partl R, Perathoner A, Gehwolf P, Kapp KS, Függer R, Öfner D, Emmanuel K. Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis. World J Surg Oncol 2019;17:146. [PMID: 31426805 DOI: 10.1186/s12957-019-1693-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
18 Tanabe K, Saeki Y, Ohta H, Ohdan H. Successful robotic proximal gastrectomy with side overlap esophagogastrostomy following preoperative chemotherapy: A case report. International Journal of Surgery Case Reports 2022;94:107040. [DOI: 10.1016/j.ijscr.2022.107040] [Reference Citation Analysis]
19 Diaz LI, Mony S, Klapman J. Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer. Ann Transl Med 2020;8:1106. [PMID: 33145325 DOI: 10.21037/atm-20-4143] [Reference Citation Analysis]
20 Tullio V, Gasperi V, Catani MV, Savini I. The Impact of Whole Grain Intake on Gastrointestinal Tumors: A Focus on Colorectal, Gastric, and Esophageal Cancers. Nutrients 2020;13:E81. [PMID: 33383776 DOI: 10.3390/nu13010081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mönig S, van Hootegem S, Chevallay M, Wijnhoven BPL. The role of surgery in advanced disease for esophageal and junctional cancer. Best Pract Res Clin Gastroenterol 2018;36-37:91-6. [PMID: 30551863 DOI: 10.1016/j.bpg.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Takeuchi M, Kawakubo H, Matsuda S, Mayanagi S, Irino T, Okui J, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y. Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer. World J Gastrointest Surg 2022; 14(1): 46-55 [DOI: 10.4240/wjgs.v14.i1.46] [Reference Citation Analysis]